Estadístiques de Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study
Visites totals
| views | |
|---|---|
| Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study | 61 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 2 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Abella_lsa_effi.pdf(legacy) | 38 |
| Abella_lsa_effi.pdf | 35 |
Vistes principals per país
| views | |
|---|---|
| United States | 45 |
| Spain | 7 |
| Australia | 2 |
| Canada | 2 |
| Belgium | 1 |
| Ireland | 1 |
| Israel | 1 |
| Malaysia | 1 |
| Puerto Rico | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Boardman | 10 |
| Ann Arbor | 7 |
| Mountain View | 5 |
| San Ramon | 5 |
| Ashburn | 3 |
| Dearborn | 2 |
| Fairfield | 2 |
| Girona | 2 |
| Madrid | 2 |
| Redmond | 2 |
| San Diego | 2 |
| Santander | 2 |
| Aguadilla | 1 |
| Cupertino | 1 |
| Durham | 1 |
| Menlo Park | 1 |
| Seattle | 1 |
| Shah Alam | 1 |
| Toronto | 1 |
| Valencia | 1 |
| Winnipeg | 1 |